THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.
作者信息
Harris J S, Michel H O
机构信息
Department of Pediatrics, Duke University School of Medicine, Durham.
出版信息
J Clin Invest. 1939 Sep;18(5):507-19. doi: 10.1172/JCI101064.
Abstract
摘要
相似文献
1
THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.
J Clin Invest. 1939 Sep;18(5):507-19. doi: 10.1172/JCI101064.
2
Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood.
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:4570-4573. doi: 10.1109/EMBC.2017.8037873.
3
Sulfhemoglobinemia after dermal application of DMSO.
Vet Hum Toxicol. 1998 Apr;40(2):87-9.
4
Pitfalls in discriminating sulfhemoglobin from methemoglobin.
Clin Chem. 1997 Jun;43(6 Pt 1):1098-9.
5
SPECTROPHOTOMETRIC DETERMINATION OF ABNORMAL HEMOGLOBIN PIGMENTS IN BLOOD.
Clin Chim Acta. 1965 Feb;11:146-58. doi: 10.1016/0009-8981(65)90209-3.
6
THE ROLE OF NONHEMOGLOBIN PROTEINS AND REDUCED GLUTATHIONE IN THE PROTECTION OF HEMOGLOBIN FROM OXIDATION IN VITRO.
J Clin Invest. 1964 Jan;43(1):17-26. doi: 10.1172/JCI104889.
7
8
Mechanism of formation of sulphhaemoglobin.
Biochim Biophys Acta. 1968 Feb 1;156(1):97-108. doi: 10.1016/0304-4165(68)90108-6.
9
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variants.
Int J Lab Hematol. 2021 Aug;43(4):837-844. doi: 10.1111/ijlh.13581. Epub 2021 Jun 6.
10
[Spectrum properties of sulfhemoglobin and a method for its determination].
Klin Wochenschr. 1968 Jul 1;46(13):728-9. doi: 10.1007/BF01731162.
引用本文的文献
1
Blood-Dyscrasia in the Treatment of Venereal Diseases.
Br J Vener Dis. 1941 Jan;17(1-2):125-65. doi: 10.1136/sti.17.1-2.125.
2
Haemoglobinometry and the Haematocrit: M.R.C. Report.
Br Med J. 1943 Feb 20;1(4285):209-12.
3
Cyanosis of Unusual Origin in Pregnancy: (With report of a case of sulphaemoglobinaemia).
Can Med Assoc J. 1944 Apr;50(4):344-9.
4
The oxidation of sulphanilamide and sulphapyridine by hydrogen peroxide.
Biochem J. 1940 May;34(5):636-9. doi: 10.1042/bj0340636.
5
ACUTE HEMOLYTIC ANEMIA FROM THE SULFONAMIDES.
J Clin Invest. 1941 Sep;20(5):593-602. doi: 10.1172/JCI101252.
6
THE OCCURRENCE OF METHEMOGLOBINEMIA DURING SULFANILAMIDE THERAPY.
J Clin Invest. 1940 Jan;19(1):123-7. doi: 10.1172/JCI101106.
7
THE IN VITRO FORMATION OF AN OXIDIZING AGENT BY SURVIVING TISSUES AND SULFANILAMIDE.
J Clin Invest. 1939 Sep;18(5):521-6. doi: 10.1172/JCI101065.
本文引用的文献
1
Methaemoglobinaemia due to Sulphanilamide Therapy.
Can Med Assoc J. 1937 Jul;37(1):62-4.
2
TOXIC MANIFESTATIONS OF SULFANILAMIDE.
Ann Surg. 1938 Nov;108(5):808-12. doi: 10.1097/00000658-193811000-00002.
3
On sulphhaemoglobin.
J Physiol. 1907 Aug 27;36(1):62-7. doi: 10.1113/jphysiol.1907.sp001217.
4
A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL.
J Clin Invest. 1938 Nov;17(6):699-710. doi: 10.1172/JCI100997.
5
CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT.
J Clin Invest. 1938 Jul;17(4):445-7. doi: 10.1172/JCI100971.
Zotero 插件